TELA Bio, Inc. (TELA)
NASDAQ: TELA · Real-Time Price · USD
1.228
-0.008 (-0.61%)
Mar 31, 2025, 10:53 AM EDT - Market open
TELA Bio Employees
TELA Bio had 227 employees as of December 31, 2023. The number of employees increased by 54 or 31.21% compared to the previous year.
Employees
227
Change (1Y)
54
Growth (1Y)
31.21%
Revenue / Employee
$305,286
Profits / Employee
-$166,700
Market Cap
48.55M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 227 | 54 | 31.21% |
| Dec 31, 2022 | 173 | 50 | 40.65% |
| Dec 31, 2021 | 123 | 15 | 13.89% |
| Dec 31, 2020 | 108 | 19 | 21.35% |
| Dec 31, 2019 | 89 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
TELA News
- 10 days ago - TELA Bio, Inc. (TELA) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 10 days ago - TELA Bio Reports Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire
- 4 weeks ago - TELA Bio to Announce Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire
- 2 months ago - TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 months ago - TELA Bio to Participate in Piper Sandler's 36th Annual Healthcare Conference - GlobeNewsWire
- 5 months ago - TELA Bio, Inc. (TELA) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 5 months ago - TELA Bio Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of the Underwriters' Option to Purchase Additional Shares - GlobeNewsWire
- 5 months ago - TELA Bio Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants - GlobeNewsWire